Astra/Ionisの後期試験つまずきでPfizer・Alnylam・BridgeBioが上昇
Seeking Alpha ·
Pfizer ( PFE ), Alnylam Pharma ( ALNY ), and BridgeBio Pharma ( BBIO ), which market drugs for a rare heart condition known as ATTR-CM, are on the rise in the premarket on Thursday after AstraZeneca ( AZN ) and
DYAX投資家予測
上昇(ロング) 44% · 下落(ショート) 56%
合計536人参加